Guiliano A, Lewis F, Hadley K, Blaisdell FW: Bacteriology of necrotizing fasciitis. Am J Surg. 1977, 134: 52-57. 10.1016/0002-9610(77)90283-5.
Article
Google Scholar
Meleney FL: Hemolytic streptococcus gangrene. Arch Surg. 1924, 9: 317-364.
Article
Google Scholar
Stevens DL: The flesh-eating bacterium: what's next?. J Infect Dis. 1999, 179 (Suppl 2): S366-374.
Article
PubMed
Google Scholar
Chelsom J, Halstensen A, Haga T, Hφiby EA: Necrotising fasciitis due to group A streptococci in western Norway: incidence and clinical features. Lancet. 1994, 344: 1111-1115. 10.1016/S0140-6736(94)90629-7.
Article
CAS
PubMed
Google Scholar
Kaul R, McGeer A, Low DE, Green K, Schwartz B: Population-based surveillance for Group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Am J Med. 1997, 103: 18-24. 10.1016/S0002-9343(97)00160-5.
Article
CAS
PubMed
Google Scholar
Haywood C, McGeer A, Low D: Clinical experience with 20 cases of Group A streptococcus necrotizing fasciitis and myonecrosis: 1995 to 1997. Plast Reconst Surg. 1999, 103: 1567-1573. 10.1097/00006534-199905060-00003.
Article
CAS
PubMed
Google Scholar
Cleary PP, Kaplan EL, Handley JP, Wlazlo A, Kim MH, Hauser AR, Schlievert PM: Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980's. Lancet. 1992, 339: 518-21. 10.1016/0140-6736(92)90339-5.
Article
CAS
PubMed
Google Scholar
Carapetis JR, Currie BJ, Kaplan EL: Epidemiology and prevention of Group A streptococcal infections: acute respiratory tract infections, skin infections, and their sequelae at the close of the Twentieth Century. Clin Infect Dis. 1999, 28: 205-210.
Article
CAS
PubMed
Google Scholar
Carapetis JR, Walker AM, Hibble M, Sriprakash KS, Currie BJ: Clinical and epidemiological features of group A streptococcal bacteraemia in a region with hyperendemic superficial streptococcal infection. Epidemiol Infect. 1999, 122: 59-65. 10.1017/S0950268898001952.
Article
CAS
PubMed
PubMed Central
Google Scholar
Trewin D: Population Distribution: Aboriginal and Torres Strait Islander Australians 2001–2002. Australian Bureau of Statistics, Canberra, Australia.
The Working Group on Severe Streptococcal Infections: Defining the group A streptococcal toxic shock syndrome: Rationale and consensus definition. JAMA. 1993, 269: 390-391. 10.1001/jama.269.3.390.
Article
Google Scholar
Beall B, Facklam R, Thompson T: Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol. 1996, 34: 953-958.
CAS
PubMed
PubMed Central
Google Scholar
Streptococcus pyogenes emm sequence database. [http://www.cdc.gov/ncidod/biotech/strep/strepblast.htm]
Gracey M, Williams P, Smith P: Aboriginal Deaths in Western Australia: 1985–89 and 1990–94. Aust N Z J Public Health. 2000, 24: 145-152.
Article
CAS
PubMed
Google Scholar
Cunningham J, Condon JR: Premature mortality in aboriginal adults in the Northern Territory, 1979–1991. Med J Aust. 1996, 165: 309-312.
CAS
PubMed
Google Scholar
Sellers B, Woods M, Morris S, Saffle J: Necrotizing group A streptococcal infections associated with streptococcal toxic shock syndrome. Am J Surg. 1996, 172: 523-528. 10.1016/S0002-9610(96)00248-6.
Article
CAS
PubMed
Google Scholar
Simonart T, Simonart JM, Derdelinckx I, De Dobbeleer G, Verleysen A, Verraes S, de Maubeuge J, Van Vooren JP, Naeyaert JM, de la Brassine M, Peetermans WE, Heenen M: Value of standard laboratory tests for the early recognition of group A β-haemolytic streptococcal necrotizing fasciitis. Clin Infect Dis. 2001, 32: e9-12. 10.1086/317525.
Article
CAS
PubMed
Google Scholar
Wall DB, Klein SR, Black S, de Virgilio C: A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J Am Coll Surg. 2000, 191: 227-231. 10.1016/S1072-7515(00)00318-5.
Article
CAS
PubMed
Google Scholar
Sudarsky L, Laschinger J, Coppa G, Spencer F: Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg. 1987, 206: 661-665.
Article
CAS
PubMed
PubMed Central
Google Scholar
Majeski J, Alexander J: Early diagnosis, nutritional support and immediate extensive debridement improve survival in necrotizing fasciitis. Am J Surg. 1983, 145: 784-787. 10.1016/0002-9610(83)90140-X.
Article
CAS
PubMed
Google Scholar
Writing Group for Therapeutic Guidelines: Antibiotic Therapeutic Guidelines: Antibiotic. 2003, Melbourne: Therapeutic Guidelines Ltd, 12
Google Scholar
Gilbert D, Moellering R, Sande M: The Sanford Guide to Antimicrobial Therapy. 2002, Hyde Park, VT: Antimicrobial Therapy Inc, 32
Google Scholar
Adams EM, Gudmundsson S, Yocum DE, Haselby RC, Craig WA, Sundstrom WR: Streptococcal myositis. Arch Int Med. 1985, 145: 1020-1023. 10.1001/archinte.145.6.1020.
Article
CAS
Google Scholar
Eagle H: Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med. 1952, 13: 389-399. 10.1016/0002-9343(52)90293-3.
Article
CAS
PubMed
Google Scholar
Stevens DL, Yan S, Bryant AE: Penicillin binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis. 1993, 167: 1401-1405.
Article
CAS
PubMed
Google Scholar
Stevens DL, Bryant-Gibbons AE, Bergstrom R, Winn V: The Eagle effect revisited: Efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis. 1988, 158: 23-28.
Article
CAS
PubMed
Google Scholar
Stevens DL, Bryant AE, Hackett SP: Antibiotic effects on bacterial viability, toxin production, and host response. Clin Infect Dis. 1995, 20 (Suppl 2): S154-157.
Article
CAS
PubMed
Google Scholar
Zimbelman J, Palmer A, Todd J: Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J. 1999, 18: 1096-1100. 10.1097/00006454-199912000-00014.
Article
CAS
PubMed
Google Scholar
Mulla ZD, Leaverton PE, Wiersma ST: Invasive group A streptococcal infections in Florida. South Med J. 2003, 96: 968-973. 10.1097/01.SMJ.0000051060.95210.9A.
Article
PubMed
Google Scholar
O'Brien CD, Manaker S: Hyperbaric oxygen therapy. In: UpToDate? Version 11.1. UpToDate, Wellesley, MA. 2003
Google Scholar
Clark LA, Moon RE: Hyperbaric oxygen in the treatment of life-threatening soft-tissue infections. Respir Care Clin N Am. 1999, 5: 203-219.
CAS
PubMed
Google Scholar
Zamboni WA, Mazolewski PJ, Erdmann D, Bergman BA, Hussman J, Cooper MD, Smoot EC, Russell RC: Evaluation of penicillin and hyperbaric oxygen in the treatment of streptococcal myositis. Ann Plast Surg. 1997, 39: 131-136.
Article
CAS
PubMed
Google Scholar
Riseman JA, Zamboni WA, Curtis A, Graham DR, Konrad HR, Ross DS: Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery. 1990, 108: 847-850.
CAS
PubMed
Google Scholar
Shupak A, Shoshani O, Goldenberg I, Barzilai A, Moskuna R, Bursztein S: Necrotizing fasciitis: an indication for hyperbaric oxygen therapy?. Surgery. 1995, 118: 873-878.
Article
CAS
PubMed
Google Scholar
Norrby-Teglund A, Stevens DL: Novel therapies in streptococcal toxic shock syndrome: attenuation of virulence factor expression and modulation of the host response. Curr Opin Infect Dis. 1998, 11: 285-291.
Article
CAS
PubMed
Google Scholar
Watanabe-Ohnishi R, Low D, McGeer A, Stevens DL, Schlievert PM, Newton D, Schwartz B, Kreiswirth B, Kotb M: Selective depletion of Vβ-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. J Infect Dis. 1995, 171: 74-84.
Article
CAS
PubMed
Google Scholar
Holm SE, Norrby A, Bergholm A, Norgren M: Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988–1989. J Infect Dis. 1992, 166: 31-37.
Article
CAS
PubMed
Google Scholar
Norrby-Teglund A, Kaul R, Low DE, McGeer A, Newton DW, Andersson J, Andersson U, Kotb M: Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J Immunol. 1996, 156: 3057-3064.
CAS
PubMed
Google Scholar
Norrby-Teglund A, Thulin P, Gan BS, Kotb M, McGeer A, Andersson J, Low DE: Evidence for superantigen involvement in severe group A streptococcal tissue infections. J Infect Dis. 2001, 184: 853-860. 10.1086/323443.
Article
CAS
PubMed
Google Scholar
Darenberg J, Ihendyane N, Sjolin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A, StreptIg Study Group: Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003, 37: 333-340. 10.1086/376630.
Article
CAS
PubMed
Google Scholar
Barry W, Hudgins L, Donta S, Pesanti E: Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA. 1992, 267: 3315-3316. 10.1001/jama.267.24.3315.
Article
CAS
PubMed
Google Scholar
Yong JM: Necrotizing fasciitis. Lancet. 1994, 343: 1427-10.1016/S0140-6736(94)92548-8.
Article
CAS
PubMed
Google Scholar
Stevens DL: Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome. Clin Infect Dis. 1998, 26: 639-641.
Article
CAS
PubMed
Google Scholar
Martin DR, Single LA: Molecular epidemiology of group A streptococcus M type 1 infections. J Infect Dis. 1993, 167: 1112-1117.
Article
CAS
PubMed
Google Scholar
Seppala H, Vuopio-Varkila J, Osterblad M, Jahkola M, Rummukainen M, Holm SE, Huovinen P: Evaluation of methods for epidemiologic typing of group A streptococci. J Infect Dis. 1994, 169: 519-525.
Article
CAS
PubMed
Google Scholar
Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR: Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: Recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun. 1995, 63: 994-1003.
CAS
PubMed
PubMed Central
Google Scholar
Descheemaeker P, Van Loock F, Hauchecorne M, Vandamme P, Goossens H: Molecular characterisation of group A streptococci from invasive and non-invasive disease episodes in Belgium during 1993–1994. J Med Microbiol. 2000, 49: 467-471.
Article
CAS
PubMed
Google Scholar
Vlaminckx BJ, Mascini EM, Schellekens J, Schouls LM, Paauw A, Fluit AC, Novak R, Verhoef J, Schmitz FJ: Site-specific manifestations of invasive group A streptococcal disease: type distribution and corresponding patterns of virulence determinants. J Clin Microbiol. 2003, 41: 4941-4949. 10.1128/JCM.41.11.4941-4949.2003.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chatellier S, Ihendyane N, Kansal RG, Khambaty F, Basma H, Norrby-Teglund A, Low DE, McGeer A, Kotb M: Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect Immun. 2000, 68: 3523-3534. 10.1128/IAI.68.6.3523-3534.2000.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chaussee MS, Liu J, Stevens DL, Ferretti JJ: Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. J Infect Dis. 1996, 173: 901-908.
Article
CAS
PubMed
Google Scholar
Moses AE, Hidalgo-Grass C, Dan-Goor M, Jaffe J, Shetzigovsky I, Ravins M, Korenman Z, Cohen-Poradosu R, Nir-Paz R: emm typing of M nontypeable invasive group A streptococcal isolates in Israel. J Clin Microbiol. 2003, 41: 4655-4659. 10.1128/JCM.41.10.4655-4659.2003.
Article
CAS
PubMed
PubMed Central
Google Scholar